Moneycontrol PRO
LAMF
LAMF

Ayushman Kumar

Principal Correspondent, Editorial And Content, Moneycontrol

Bribery case part of ‘larger conspiracy’ to prevent me from being DCGI: S Eswara Reddy

TRENDS

Bribery case part of ‘larger conspiracy’ to prevent me from being DCGI: S Eswara Reddy

Government launches scheme for pharma sector to step up capacity, upgrade to global standards

TRENDS

Government launches scheme for pharma sector to step up capacity, upgrade to global standards

Opium processing lucrative business with high margins: Bajaj Healthcare MD Anil Jain

TRENDS

Opium processing lucrative business with high margins: Bajaj Healthcare MD Anil Jain

CBI court to pronounce order in CDSCO bribery case today

TRENDS

CBI court to pronounce order in CDSCO bribery case today

Move to open opium market to private players could take Rs 1,000 crore business to new highs

BUSINESS

Move to open opium market to private players could take Rs 1,000 crore business to new highs

CBI special court reserves S Eswara's bail application in bribery case

INDIA

CBI special court reserves S Eswara's bail application in bribery case

MC Explains | What is Cervavac? India’s first cervical cancer vaccine

TRENDS

MC Explains | What is Cervavac? India’s first cervical cancer vaccine

Tax raids on Dolo 650 maker, officials say cash, jewellery worth Rs 2.6 crore seized

TRENDS

Tax raids on Dolo 650 maker, officials say cash, jewellery worth Rs 2.6 crore seized

Centre plans second-generation COVID vaccines to tackle mutating variants 

TRENDS

Centre plans second-generation COVID vaccines to tackle mutating variants 

Bajaj Healthcare enters tightly regulated but lucrative opium-processing business

TRENDS

Bajaj Healthcare enters tightly regulated but lucrative opium-processing business

PIVOT: The AI-based tool that can predict cancer-causing genes

TRENDS

PIVOT: The AI-based tool that can predict cancer-causing genes

Research crucial for Indian pharma industry to move from ‘volume’ to ‘value’: Mansukh Mandaviya

INDIA

Research crucial for Indian pharma industry to move from ‘volume’ to ‘value’: Mansukh Mandaviya

NTAGI's technical sub-committee recommends use of Corbevax, Covaxin for children between 5-12 years

INDIA

NTAGI's technical sub-committee recommends use of Corbevax, Covaxin for children between 5-12 years

High levels of toxic chemical detected in drinking water across India

INDIA

High levels of toxic chemical detected in drinking water across India

Healthcare associations write to FM, raise concerns over 5% GST on hospital room rent

TRENDS

Healthcare associations write to FM, raise concerns over 5% GST on hospital room rent

As CGHS dues pile up, private hospitals refuse cashless treatment to govt employees

INDIA

As CGHS dues pile up, private hospitals refuse cashless treatment to govt employees

Discontinue GST exemption on healthcare services; allow input tax credit, FICCI tells FM Sitharaman

TRENDS

Discontinue GST exemption on healthcare services; allow input tax credit, FICCI tells FM Sitharaman

Akums Drugs gets European Union GMP nod for two manufacturing plants in Haridwar

TRENDS

Akums Drugs gets European Union GMP nod for two manufacturing plants in Haridwar

Taxing patients: Hospitals protest decision to raise GST on hospital room rents above 5K a day  

TRENDS

Taxing patients: Hospitals protest decision to raise GST on hospital room rents above 5K a day  

Zydus gets USFDA's final approval for Lacosamide injection

INDIA

Zydus gets USFDA's final approval for Lacosamide injection

mRNA booster shot in pipeline, says Gennova Biopharmaceuticals

TRENDS

mRNA booster shot in pipeline, says Gennova Biopharmaceuticals

MC Explains | GEMCOVAC-19, India's first mRNA Covid-19 vaccine, and how it scores over Pfizer, Moderna

TRENDS

MC Explains | GEMCOVAC-19, India's first mRNA Covid-19 vaccine, and how it scores over Pfizer, Moderna

Aiming for sustainable innovation with affordable CAR-T therapy in India: Arun Anand, COO, Immuneel Therapeutics

TRENDS

Aiming for sustainable innovation with affordable CAR-T therapy in India: Arun Anand, COO, Immuneel Therapeutics

From non-availability of boosters to pending visa clearances, no end to miseries for Sputnik V takers in India

TRENDS

From non-availability of boosters to pending visa clearances, no end to miseries for Sputnik V takers in India

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347